PIK3CD and non-small cell lung carcinoma: As redundant activators of the PI3K/AKT signaling pathway and negative feedback loops [5] limit the efficacy of single agent therapies, our next purpose was to study the effects of targeting the PI3K/AKT signaling pathway at multiple levels in NSCLC cell lines.